tiprankstipranks
Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs
Company Announcements

Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs

Kissei Pharmaceutical Co (JP:4547) has released an update.

Don't Miss our Black Friday Offers:

Kissei Pharmaceutical Co reported a 14.8% increase in net sales for the second quarter of Fiscal 2024, driven by its Pharmaceutical Business, despite a decline in operating profit due to rising R&D expenses. The company’s expansion of key and new products contributed significantly to the sales growth.

For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskKissei Pharmaceutical Finalizes Share Buyback and Cancellation
TipRanks Japan Auto-Generated NewsdeskKissei Pharmaceutical Plans Share Buyback and Cancellation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App